Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
TuHURA Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 2.03 · gapped below the open, then crossed back over prior close. High/low 2.04 at 6:15 pm ET, 2.00 at 11:00 am ET.
82 institutional managers report a position in TuHURA Biosciences, Inc. worth $20.9M between them, filed on form 13F for the quarter ending 2026-06-30. 13 of them hold 80% of it, the largest being Vanguard Capital Management LLC at 25.35%.
57 more managers in the register
13 managers hold 80% of the $20.9M institutional base. The other 69 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Qube Research & Technologies Ltd, Captrust Financial Advisors, Tudor Investment Corp ET AL +3 more · 1.63% of HURA, 3.33% of SLQT
via Qube Research & Technologies Ltd, Captrust Financial Advisors, Tudor Investment Corp ET AL +2 more · 1.63% of HURA, 2.27% of IIIN
via Qube Research & Technologies Ltd, Aster Capital Management (DIFC) Ltd, Tudor Investment Corp ET AL +1 more · 1.63% of HURA, 1.29% of SKYX
via Qube Research & Technologies Ltd, Captrust Financial Advisors, Tudor Investment Corp ET AL +1 more · 1.63% of HURA, 1.15% of BRX
via Qube Research & Technologies Ltd, Tudor Investment Corp ET AL, IEQ Capital, LLC +1 more · 1.63% of HURA, 2.11% of BLZE
via Qube Research & Technologies Ltd, Leucadia National Corp, Cetera Investment Advisers +2 more · 1.63% of HURA, 1.23% of HTGC
Managers holding a meaningful stake in HURA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
HURA (TuHURA Biosciences, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: MRK −0.01%, in healthcare.